GILD
Gilead Sciences Inc
stockNASDAQ
Market OpenOct 28, 2026 1:25:22 PM EDT
159.52USD+0.277%(+0.44)1,931,226
Loading…
Loading…
197.74B
Healthcare
Drug Manufacturers-General
HQ
Foster City, CA, USA
10,000
Previous Close
$159.08
Beta
0.31
52-Week High
$160.51 2026-10-15
52-Week Low
$114.02 2025-10-31
SMA 50
$149.65
SMA 200
$139.25
Avg. Vol 10D
6.39M
Avg. Vol 30D
6.10M
Avg. Vol 90D
6.44M
Relative Vol
0.31
1.24B
1.24B
99.79%
20,270,007
1.64%
3.72
58%/42%
50.63%
42.07%
0.4100%
9,600,000
1,997
1,374
2,100
Oct 29, 2026 (1d)
Sep 15, 2026 · $0.820
Jan 28, 2013 · 2-for-1
30.5B
-3.2B
12.9B
-20.57
Oct 28, 2026
Gilead Sciences stock hits all-time high at 160.51 USD · 
Investing.com
Oct 26, 2026
Oct 25, 2026
Earnings Week Ahead: MSFT, GOOGL, AMZN, XOM, BA, VZ, and more · 
Seeking Alpha
Oct 23, 2026
GILD Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
GILD Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 153.57 | 2026-10-21 | +3.85% | -0.275 |
| 1M | 152.21 | 2026-09-28 | +4.77% | -0.663 |
| 3M | 134.32 | 2026-07-28 | +18.73% | 0.258 |
| 6M | 129.26 | 2026-04-28 | +23.38% | 0.096 |
| 1Y | 117.88 | 2025-10-28 | +35.29% | 0.307 |
| 2Y | 88.76 | 2024-10-28 | +79.67% | — |
| 5Y | 67.34 | 2021-10-28 | +136.82% | 0.401 |
GILD Stock Summary
Gilead Sciences Inc (NASDAQ:GILD) stock price today is $159.48, and today's volume is 1,910,800. GILD is up 0.248% today. The 30 day average volume is 6.10M. GILD market cap is $197.74B with 1.24B shares outstanding.